Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

IMP dehydrogenase inhibitor synthesized at Roche Bioscience

May 17, 1996

CD45RB for organ transplant rejection

May 10, 1996

Cel-Sci announces promising results with TB vaccine

May 10, 1996

Axis Genetics scales up CVP production in anticipation of clinical trials

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Positive results obtained in AllerVax Cat trial

May 3, 1996

HemispheRx, Helix will codevelop nucleic acid compounds

May 3, 1996

ALT expected to receive streamlined review at FDA

May 3, 1996

Centeon to codevelop Medarex's MDX-33

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...